Skip to main content
Log in

Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2011

  • Clinical Trial Updates and Hotline Sessions
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

This article provides information and commentaries on trials which were presented at the Hotline and Clinical Trial Update Sessions during the Late Breaking Clinical Trial Sessions at the 60th annual meeting of the American College of Cardiology in New Orleans, USA, from 2nd April to 5th April 2011. This article gives an overview on a number of novel clinical trials in the field of cardiovascular medicine, which were presented. The comprehensive summaries have been generated from the oral presentation and the webcasts of the American College of Cardiology, similar as previousely reported (Gensch et al. Clin Res Cardiol 100:1–9, 2011; Lenski et al. Clin Res Cardiol 99:679–692, 2010) and should provide the readers with the most comprehensive information of relevant publications. The data were presented by leading experts in the field with relevant positions in the trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gensch C, Hoppe U, Böhm M, Laufs U (2011) Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010. Clin Res Cardiol 100:1–9

    Article  PubMed  Google Scholar 

  2. Lenski M, Mahfoud F, Werner C, Bauer A, Böhm M (2010) Hotline sessions and clinical trial updates presented at the European Society of Cardiology Congress in Stockholm. Clin Res Cardiol 99:679–692

    Article  PubMed  Google Scholar 

  3. Figulla L, Neumann A, Figulla HR, Kahlert P, Erbel R, Neumann T (2011) Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol 100:265–276

    Article  PubMed  CAS  Google Scholar 

  4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D (2010) Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607

    Article  PubMed  CAS  Google Scholar 

  5. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Chung CH, Lee JW, Lim DS, Rha SW, Lee SG, Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB (2011) Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. doi:10.1056/NEJMoa1100452

  6. Feldman T, Foster E, Glower DG et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. doi:10.1056/NEJMoa1009355

  7. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O’Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL; the STICH Investigators (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. doi:10.1056/NEJMoa1100356

  8. Maier L, Baumhäkel M, Böhm M (2009) Hotline sessions presented at the American College of Cardiology Congress 2009. Clin Res Cardiol 98:345–352

    Article  PubMed  Google Scholar 

  9. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza AJ; the STICH Trial Investigators (2011) Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. doi:10.1056/NEJMoa1100358

  10. Mehili J (2011) Randomized, superiority trial of drug-eluting stent and bare metal stent in saphenous vein graft lesions. In: American College of Cardiology Scientific Sessions/i2 Summit SCAI annual meeting. Late breaking clinical trials. New Orleans, 2–5 April

  11. Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR; for the RIVAL trial group (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. doi:10.1016/S0140-6736(11)60404-2

  12. Alan CY, Martin BL, Ash J, Thaddeus RT, Douglas JS, Brent TM, Jeffrey JP, Peter JF, Donald EC, Joseph MM, Laura M, RESOLUTE US Investigators (2011) Clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries. The RESOLUTE US Clinical Trial. J Am Coll Cardiol. doi:10.1016/j.jacc.2011.03.005

  13. Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD, PLATINUM Trial Investigators (2011) A prospective, randomized evaluation of a novel everolimus-eluting coronary stent The PLATINUM (A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the treatment of up to two de novo coronary artery lesions) Trial. J Am Coll Cardiol. doi:10.1016/j.jacc.2011.02.016

  14. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M (2007) VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 98:756–764

    PubMed  CAS  Google Scholar 

  15. Leizorovicz A, Mismetti P (2004) Preventing venous thromboembolism in medical patients. Circulation 110:IV13–IV19

    PubMed  Google Scholar 

  16. Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG (2005) Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 94:750–759

    PubMed  Google Scholar 

  17. Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos A, Tapson V (2011) Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis. doi:10.1007/s11239-011-0549-x

  18. Hendricks JML (2011) Specialised atrial fibrillation clinic reduces cardiovascular morbidity and mortality in patients with atrial fibrillation. In: American College of Cardiology Scientific Sessions/i2 Summit SCAI annual meeting. Late breaking clinical trials. New Orleans 2–5 April

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Walenta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walenta, K., Sinning, J.M., Werner, N. et al. Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2011. Clin Res Cardiol 100, 475–482 (2011). https://doi.org/10.1007/s00392-011-0322-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-011-0322-3

Keywords

Navigation